New Data at EADV 2020 Confirm Taltz® (ixekizumab) Demonstrates Sustained Long-Term Efficacy in Patients with Psoriasis and Psoriatic Arthritis
Agencia Latina de Noticias de Medicina y Salud Pública Long-term and post-hoc analysis data show continued efficacy of Taltz in treating challenging...